SARC024 August 31, 2021 Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• Children’s Hospital of Los Angeles• Mayo Clinic (Jacksonville, FL)• Mayo Clinic (Rochester, MN)• Ohio State University (Columbus, OH)• Oregon Health and Sciences University (Portland, OR)• Texas Children’s Hospital (Houston, TX)• Vanderbilt University (Nashville, TN) Click the button below to learn more about this study and to view Dr. Maki’s SARC024 presentation at the 2021 SARC Semiannual Meeting. sarc024 presentation